The therapeutic benefit and toxicity from multiple myeloma phase I trials, 2004 through 2014.

被引：0
|
作者：
Malek, Ehsan
Driscoll, James J.
Welge, Jeffrey
机构：
[1] Univ Cincinnati, Div Hematol & Oncol, Cincinnati, OH USA
[2] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8585
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Survival gains in multiple myeloma from 2003 to 2014.
    Fonseca, Rafael
    Jena, Anupam B.
    Peneva, Desi
    Clancy, Zoe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [2] Rethinking Risk-Benefit Assessment for Phase I Multiple Myeloma Trials
    Malek, Ehsan
    Saygin, Caner
    Ye, Rebecca
    Kim, Byung-gyu
    Covut, Fahrettin
    De Lima, Marcos
    Driscoll, James J.
    [J]. BLOOD, 2016, 128 (22)
  • [3] Is there a therapeutic benefit for patients participating in modern phase I trials?
    Stein, M. N.
    Tan, A. R.
    Mehnert, J. M.
    Gibbon, D.
    DiPaola, R. S.
    Moss, R. A.
    Poplin, E.
    Rubin, E. H.
    Saraiya, B.
    Kane, M. P.
    Scott, P.
    LaRosiliere, M.
    Camisa, H.
    Kirin, P.
    Thomas, C. M.
    Aisner, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Patient Expectations of Benefit from Phase I Clinical Trials: Linguistic Considerations in Diagnosing a Therapeutic Misconception
    K.P. Weinfurt
    Daniel P. Sulmasy
    Kevin A. Schulman
    Neal J. Meropol
    [J]. Theoretical Medicine and Bioethics, 2003, 24 : 329 - 344
  • [5] Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutic misconception
    Weinfurt, KP
    Sulmasy, DP
    Schulman, KA
    Meropol, NJ
    [J]. THEORETICAL MEDICINE AND BIOETHICS, 2003, 24 (04) : 329 - 344
  • [6] Do elderly patients benefit from enrollment into Phase I Trials?
    Tai, Wai Meng
    Lim, Cindy
    Ahmad, Aziah
    Ong, Whee Sze
    Choo, Su Pin
    Lim, Wan Teck
    Tan, Eng Huat
    Kanesvaran, Ravindran
    Tan, Daniel Shao Weng
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2015, 6 (03) : 241 - 248
  • [7] Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis
    van Nieuwenhuijzen, Niels
    Frunt, Rowan
    May, Anne M.
    Minnema, Monique C.
    [J]. BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [8] Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis
    Niels van Nieuwenhuijzen
    Rowan Frunt
    Anne M. May
    Monique C. Minnema
    [J]. Blood Cancer Journal, 11
  • [9] Do elderly patients benefit from enrollment in phase I clinical trials?
    Tai, Wai Meng David
    Lim, Cindy
    Ahmad, Aziah
    Ong, Whee Sze
    Choo, SuPin
    Lim, Wan-Teck
    Tan, Eng-Huat
    Tan, Daniel Shao-Weng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers
    Hlubocky, Fay J.
    Sher, Tamara G.
    Cella, David
    Wroblewski, Kristen E.
    Peppercorn, Jeffery
    Daugherty, Christopher K.
    [J]. JCO ONCOLOGY PRACTICE, 2021, 17 (02) : E101 - E110
12345